Skip to content

Exploring the Benefits of Meditation for Chronic Kidney Disease A Preliminary Study

The Effect of Meditation as an Adjuvant Therapy in Chronic Kidney Disease CKD A Pilot Study - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/073040
Enrollment
40
Registered
2024-08-28
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N186- End stage renal disease

Interventions

Intervention1: Meditation + Standard care: The intervention in this study is a mantra-based meditation along with standard care. Each session will roughly be 15 minutes twice a day. The experimental g

Sponsors

Dr Ashween Bilagi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with CKD and undergoing dialysis 2. Those who have given informed consent for completing the study 3. Those who are mentally and physically fit up to a minimum level to understand and perform the practices will be included.

Exclusion criteria

Exclusion criteria: 1. Participants with a history of substance abuse, psychotic illnesses, and those on therapy for psychotic illness. 2. Other chronic conditions, such as recent stroke and post-coronary artery bypass grafting. 3. Recent abdominal surgeries. 4. Solid organ or bone marrow transplant. 5. Active malignancy in the last 2 years. 6. Palpitations or dyspnoea at rest or asymptomatic only when resting. 7. Pregnant women. 8. Those who are currently on immunosuppressive drug therapy. 9. Those with an expected life expectancy of less than 1 year. 10. Those with vocal cords or speech problems. 11. Those with exposure to yoga and meditation in the past 3 months.

Design outcomes

Primary

MeasureTime frame
Heart Rate Variability Health-Related Quality of LifeTimepoint: Data collection will be done first at baseline on the 0th day. Intervention will be given from day 1 to day 30. Post-data collection will be done on the 31st day.

Secondary

MeasureTime frame
Perceived stress levels Level of mindfulnessTimepoint: Data collection will be done first at baseline on the 0th day. Intervention will be given from day 1 to day 30. Post-data collection will be done on the 31st day.

Countries

India

Contacts

Public ContactDr Ashween Bilagi

Sri Devaraj Urs Academy of Higher Education and Research

ayushashwin@gmail.com9886666636

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026